NCT01540071 2021-05-14Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate CancerIo TherapeuticsPhase 2 Completed38 enrolled 11 charts
NCT00630760 2014-05-21Oral NRX 194204 in Patients With Refractory MalignanciesUniversity of Southern CaliforniaPhase 1 Terminated24 enrolled
NCT00964132 2009-09-03Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)NuRx Pharmaceuticals, Inc.Phase 2 Unknown48 enrolled